跳至主要内容
临床试验/RBR-9th6k46
RBR-9th6k46
招募中
3 期

Hydrocortisone versus placebo for severe Hospital-acquired Pneumonia in intensive care patients

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo0 个研究点2022年8月15日

概览

阶段
3 期
干预措施
未指定
疾病 / 适应症
Healthcare-Associated Pneumonia
发起方
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
状态
招募中
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2022年8月15日
结束日期
2024年6月30日
最后更新
2年前
研究类型
Intervention

研究者

发起方
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

入排标准

入选标准

  • 18 years of age or older; Suspected or confirmed case of bacterial nosocomial pneumonia (including ventilator\-associated pneumonia); Intensive Care Unit stay; Signed consent form (by the patient or a legal guardian)

排除标准

  • Women who are pregnant, have recently given birth or are breastfeeding; Patients who are moribund or do not have a treatment perspective; Patients with community acquired pneumonia; Patients with other types of pneumonia; Those with pulmonary infiltrates in chest image which are not compatible with bacterial pneumonia; Patients with adrenal insufficiency; Patients who have a condition that demands the use of corticosteroids (acute or chronic); Patients allergic to hydrocortisone; Patients with refractory septic shock (those receiving more than 0,5mcg/kg/min of norepinephrine)

结局指标

主要结局

未指定

相似试验